非動(dòng)脈炎性前部缺血性視神經(jīng)病變相關(guān)因素分析
[Abstract]:Objective to investigate the etiology, pathogenesis, risk factors, clinical features, treatment methods, therapeutic effects and preventive measures of non-arteritic anterior ischemic optic neuropathy in patients with non-arterial inflammatory anterior ischemic optic neuropathy. In order to provide clinicians with more powerful evidence to guide clinical diagnosis and treatment. Methods retrospective case analysis was used. From April 2011 to November 2016, 66 patients (74 eyes) with NAION admitted to the fourth Central Hospital of Tianjin were collected and analyzed their clinical manifestations, ocular and systemic risk factors, visual acuity and visual field. The results of fundus fluorescein angiography (fundus fluorescein) and optical coherence tomography (Oct) were used to treat systemic diseases, and the patients were treated with glucocorticoids, vasodilators and neurotrophic agents. The changes of corrected visual acuity and visual field before and after treatment were compared. Results the ratio of male to female was 1.6: 1, and the mean age of onset was (58.6 鹵10.4) years. All the patients showed different degrees of central visual acuity decline and visual field change. In 71 eyes, the quadrant or inferior visual field defect around the central fixation point was connected with the physiological blind spot, 36 eyes (50.7%). The ocular fundus examination showed ischemic water in the optic papilla. In 66 eyes (89.2%) with FFA, 45 eyes (60.8%) showed delayed filling and late fluorescence enhancement of optic papilla. There were 46 cases (69.7%) with hypertension, 26 cases (39.4%) with diabetes, 37 cases (56.0%) with hyperlipidemia and 19 cases (28.8%) with smoking history. The visual acuity was improved in 38 eyes, the effective rate was 51.4, and the visual field defect was improved in 34 eyes, the effective rate was that 47.9%.FFA showed that the filling time of early optic nipple was shorter in 19 eyes than that in the early stage. The ischemic area was smaller in 31 eyes than in the early stage. Conclusion NAION is a kind of ocular disease related to various diseases and factors of the whole body and local eye. Hypertension diabetes hyperlipidemia or arteriosclerosis ignoring cup or cup raising intraocular pressure and smoking are the risk factors. In the course of clinical diagnosis and treatment, attention should be paid to the improvement of examination measures and definite diagnosis. After active comprehensive treatment, the central visual acuity and visual field of some patients can be improved to some extent.
【學(xué)位授予單位】:天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R774.6
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李春霞;劉文舟;;前部缺血性視神經(jīng)病變與大腦多發(fā)性缺血灶的臨床分析[J];中國眼耳鼻喉科雜志;2016年06期
2 周潔;周希瑗;;非動(dòng)脈炎性前部缺血性視神經(jīng)病變的發(fā)病機(jī)制及危險(xiǎn)因素[J];國際眼科縱覽;2016年05期
3 馮雨;萬新順;賈新萍;趙慶新;;非炎癥性前部缺血性視神經(jīng)病變對側(cè)眼的血流動(dòng)力學(xué)觀察[J];河南醫(yī)學(xué)研究;2016年10期
4 田國紅;;非動(dòng)脈炎性前部缺血性視神經(jīng)病變的診斷及鑒別診斷[J];中國眼耳鼻喉科雜志;2016年05期
5 接英;阮方;李上;郭純剛;;非動(dòng)脈炎型前部缺血性視神經(jīng)病變的臨床特點(diǎn)分析[J];眼科新進(jìn)展;2016年07期
6 陸新安;阮丹;徐春柳;范迪柳;王凱軍;;復(fù)方樟柳堿注射液治療缺血性視神經(jīng)病變的療效觀察[J];中國生化藥物雜志;2016年02期
7 關(guān)倩;王春芳;岳雪梅;;前部缺血性視神經(jīng)病變的危險(xiǎn)因素研究進(jìn)展[J];中國中醫(yī)眼科雜志;2016年01期
8 曹珊珊;李紅陽;康皓;姜兆財(cái);劉子豪;魏世輝;;50歲以下的非動(dòng)脈炎性前部缺血性視神經(jīng)病變患者的臨床特點(diǎn)[J];中國中醫(yī)眼科雜志;2016年01期
9 趙朋波;周劍;蘇艷;李麗;閆曉玲;谷心怡;吳魯華;韋企平;;光學(xué)相干斷層掃描技術(shù)在前部缺血性視神經(jīng)病變不同病程中的應(yīng)用[J];中國中醫(yī)眼科雜志;2016年01期
10 陳婷;單廣良;馬瑾;鐘勇;;非動(dòng)脈炎性前部缺血性視神經(jīng)病變臨床特征及危險(xiǎn)因素分析[J];中華眼底病雜志;2015年06期
,本文編號(hào):2140550
本文鏈接:http://sikaile.net/yixuelunwen/wuguanyixuelunwen/2140550.html